Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

NCT00234442 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Closed due to insufficient recruitment.

Conditions

Brain Neoplasms
Non Small Cell Lung Cancer

Interventions

DRUG: Iressa (Gefitinib)

Sponsor

AstraZeneca